1150263-32-3

Basic information

• Product Name: methyl 3-bromo-5-(prop-1-en-2-yl)benzoate
• Synonyms: methyl 3-bromo-5-(prop-1-en-2-yl)benzoate
• CAS NO: 1150263-32-3
• Molecular Weight: 255.111
• Mol File: 1150263-32-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: methyl 3-bromo-5-(prop-1-en-2-yl)benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 3-bromo-5-(prop-1-en-2-yl)benzoate(1150263-32-3)
• EPA Substance Registry System: methyl 3-bromo-5-(prop-1-en-2-yl)benzoate(1150263-32-3)

Safety Data

• Hazardous Substances Data: 1150263-32-3(Hazardous Substances Data)

Upstream product

• 14559-87-6 isopropenylboronic acid 
• 188813-07-2 methyl 3-bromo-5-iodobenzoate 

Downstream Products

• 1150263-34-5 3-bromo-5-isopropenylbenzoic acid 
• 1442431-05-1 3-bromo-5-(1-methylcyclopropyl)benzoic acid 
• 1442431-06-2 3-bromo-N-(tert-butyl)-N-methyl-5-(1-methylcyclopropyl)benzamide 
• 1442431-07-3 N-(tert-butyl)-N-methyl-3-(1-methylcyclopropyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide 
• 1442431-04-0 methyl 3-bromo-5-(1-methylcyclopropyl)benzoate 

Relevant articles and documents

CARBOXAMIDE OR SULFONAMIDE SUBSTITUTED NITROGEN-CONTAINING 5-MEMBERED HETEROCYCLES AS MODULATORS FOR THE ORPHAN NUCLEAR RECEPTOR ROR GAMMA

The invention provides modulators for the orphan nuclear receptor RORy and methods for treating RORy mediated diseases by administering these novel RORy modulators to a human or a mammal in need thereof. Specifically, the present invention provides carboxamide containing cyclic compounds of Formula (1) to Formula (5) and the enantiomers, diastereomers, tautomers, /V-oxides, solvates and pharmaceutically acceptable salts thereof.

CARBOXAMIDE OR SULFONAMIDE SUBSTITUTED THIAZOLES AND RELATED DERIVATIVES AS MODULATORS FOR THE ORPHAN NUCLEAR RECEPTOR ROR[GAMMA]

The invention provides modulators for the orphan nuclear receptor RORy and methods for treating RORy mediated diseases by administering these novel RORy modulators to a human or a mammal in need thereof. Specifically, the present invention provides carboxamide or sulfonamide containing cyclic compounds of Formula (1), (1'), (100), (100'), (200) and (200') and the enantiomers, diastereomers, tautomers, /V-oxides, solvates and pharmaceutically acceptable salts thereof.